> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Generic Drugs Head Retiring
- URL: https://www.fdaweb.com/fda-generic-drugs-head-retiring/
- Published: 2018-07-17T12:00:00.000Z
- Updated: 2026-09-15T00:20:00.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5141889

CDER Office of Generic Drugs (OGD) director **Kathleen Uhl** has announced her intention to retire 2/2019\. Uhl joined FDA in 1998 as a CDER medical officer in clinical pharmacology. In 2010, she was appointed deputy director of CDER’s Office of Medical Policy, and became acting director of OGD in 2013 and permanent director in 2015\. FDA intends to conduct a national search to fill Uhl’s position and she will provide input on the selection of her replacement.